Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients

Abstract EN

Xanthine oxidase (XO), an isoform of xanthine oxidoreductase (XOR), is thought to increase the cardiovascular burden among chronic kidney disease (CKD) patients via oxidative radical production.

Plasma XOR redox, which is characterized by the ratio of XO to total XOR, changes under different oxidative conditions associated with kidney dysfunction.

However, the relationship between plasma XOR redox and oxidative stress (OS) is unclear.

Thus, we aimed to clarify whether OS is related to XOR redox.

We used the redox state of human serum albumin (HSA) as a marker to investigate the status of OS in CKD patients.

HSA is composed of human mercaptoalbumin (HMA), which possesses not oxidized cysteine residues, reversibly oxidized human nonmercaptoalbumin-1 (HNA-1), and strongly oxidized human nonmercaptoalbumin-2 (HNA-2).

The subjects included 13 nondialysis patients (7 males and 6 females) with varying degrees of kidney function.

We found that ƒ(HMA) was negatively (R=−0.692, P=0.0071) and ƒ(HNA-1) was positively (R=0.703, P=0.0058) correlated with plasma XO/XOR.

ƒ(HNA-2) showed no correlation with XO/XOR (R=0.146, P=0.6412), indicating that plasma XOR redox is not related to the irreversible oxidation of HSA.

In conclusion, plasma XOR redox is closely related to HSA redox, particularly reversible oxidation of HSA.